Seven Stones wins General Electric Healthcare account
December 13, 2005Medical Communications
Specialist healthcare communications agency Seven Stones has secured a new global account with General Electric Healthcare Discovery Systems.A subsidiary of …
Shire and New River expect new ADHD launch in 2006
December 8, 2005Sales and Marketing
New River Pharmaceuticals has filed a new treatment for attention deficit hyperactivity disorder (ADHD) with US regulator the FDA.New River …
350 million needed for stem cell research
December 8, 2005Research and Development
At least £350 million extra funding is needed for UK stem cell research if it is to maintain its international …
J&J submits new schizophrenia drug
December 8, 2005Sales and Marketing
Johnson & Johnson has submitted a new schizophrenia drug to the FDA, and hopes it will succeed one of its …
McKillop calls for changes to EU pharmaceutical market
December 8, 2005Research and Development
AstraZeneca's chief executive Sir Tom McKillop says action is needed on pricing and the clinical trials environment in order to …
Brooksby to be new ABPI president
December 8, 2005Sales and Marketing
Nigel Brooksby, Sanofi-Aventis UK's managing director has been named as the ABPI's next president.Brooksby will take over from the current …
Merck seeks US approval for cancer vaccine
December 7, 2005Sales and Marketing
Merck has submitted its cervical cancer vaccine Gardasil to the FDA following impressive clinical trial results against the two most …
Can CSOs lead the way?
December 7, 2005Sales and Marketing
With the spotlight shining on pharma sales teams, companies are exploring a variety of ways to improve productivity and effectiveness. …
Pharmacies offer lab tests for long-term conditions
December 7, 2005Up to 6,000 patients could benefit from a new pilot project which will see high street pharmacies providing lab tests …
UK biotech signs $230 million deal with Genentech
December 7, 2005Research and Development
UK biotech PIramed has signed a collaborative R&D deal with Genentech on a new class of cancer drugs, which could …
Research plans attract
December 7, 2005Sales and Marketing
Plans to boost UK medical research through improvements to NHS systems is set to attract an extra £1 billion investment …
CIPR to debate impact of new prescribers
December 7, 2005The CIPR Health & Medical Group will debate the new prescribing powers proposed for nurses and pharmacists at a special …
Rx Award wins for Paling Walters and LEC Advertising
December 7, 2005Medical Communications
Paling Walters and Lane Earl & Cox won prestigious awards at New York's Rx Club Awards.The agency's Lethal obsession campaign …
Communicating with patients
December 5, 2005Sales and Marketing
Despite little prospect of the restrictions in Europe on communicating directly with consumers being relaxed, the issue of DTC communications …
New UK headquarters for Bristol-Myers Squibb
December 5, 2005Sales and Marketing BMS, UK
Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.The £5.5 million building houses over 200 employees, …
Merck plans diabetes compliance campaign
December 5, 2005Medical Communications
Merck Pharmaceuticals has engaged Medicom to improve compliance in diabetic patients as part of the communications strategy for its type …
Sanofi-Aventis throws its weight behind Acomplia
December 5, 2005Sales and Marketing
Sanofi-Aventis is gearing up for the launch of its potential blockbuster Acomplia, a drug which the company wants to promote …
Scheuble quits as Merck KGaA chief
December 5, 2005Sales and Marketing
Bernhard Scheuble has stepped down as chief executive of German pharma company Merck KGaA, disagreements with the company's owners thought …
58,000 people living with HIV in the UK
December 5, 2005The number of people living with HIV in the UK is now more than 58,000 – including nearly 20,000 who …
GlaxoSmithKline’s lapatinib hailed as latest ‘wonder drug’
December 1, 2005Sales and Marketing
GlaxoSmithKline has released new data on a number of promising new drugs in its oncology pipeline – including breast cancer …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
